Unknown PHASE2 INTERVENTIONAL 1-arm NCT02226380

FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer (FOLFOX6)

A Phase II Study of Neoadjuvant Chemotherapy With Modified FOLFOX6 Regimen and Effects of Tumor Regression in Locally Advanced Gastric Cancer

Sponsor: Peking Union Medical College Hospital

Conditions Effects of Chemotherapy Gastric Cancer Surgery

Interventions mFOLFOX6 regimen

Updated 7 times since 2017 Last updated: Aug 26, 2014 Started: Oct 31, 2013 Primary completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02226380, this PHASE2 trial focuses on Effects of Chemotherapy and Gastric Cancer and remains ongoing. Sponsored by Peking Union Medical College Hospital, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Aug 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jul 2018 — Aug 2018 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jul 2018 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China